Massmutual Trust CO Fsb Arcellx, Inc. Call Options Transaction History
Massmutual Trust CO Fsb
- $3.87 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACLX
# of Institutions
223Shares Held
49.1MCall Options Held
245KPut Options Held
885K-
Paradigm Biocapital Advisors LP New York, NY4.65MShares$420 Million14.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.94MShares$356 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$338 Million20.45% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$317 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.04MShares$274 Million4.37% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.95B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...